BOARD OF DIRECTORS
The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board. Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.
Thomas M. Silver, President
Principal, Silver Dollar Ventures, LLC.
Ghaith Abu-Zeinah, MD, Chief Medical Advisor
New York-Presbyterian/Weill Cornell Medicine
David T. Boule, Treasurer
Retired Partner, Ernst & Young
Maria Brisbane, CFA
Managing Director, Morgan Stanley
Terry Hermanson
President, Mr. Christmas, Inc.
Michael C. Kempner
Managing General Partner, KS Capital Partners, LP
Kasia McCormick
Amanda Johns Perez
Jeffrey Puglisi, MD
Glenville Medical Concierge Care
Richard J. Rose
Sr. Managing Director, Shufro, Rose & Co., LLC (Retired)
Caleb Sexton
Founder and CEO, Workforcely
Raj Shah
Chief Investment Officer, The Hardy Group
Todd J. Shaw
Senior Vice President, Morgan Stanley
AJ Shiekman
Strategy/Business Development Manager, Pure Storage
Adam Silver
Tim Silver
Portfolio Manager, Empery Asset Management, LP
Anne Templeton
Past CR&T Presidents
Thomas M. Silver, 2015-present
David Boule, 2014-2015
Douglas McCormick, 2009-2013
Richard J. Rose, 1996-2008
Hank Seiden, 1993-1995
William R. Johnston, 1988-1992
Joan Shaw, 1983-1988
John “Big” Wilson, ?-1983
Counsel
Nelson A. Boxer
Partner, Petrillo Klein & Boxer LLP
Emeritus Directors
Richard T. Silver, MD
Founder, Vice President and Chief Medical Officer, Emeritus
Staff
Michael Gurtowski
VP of Administration and Development
Mara Sanderson
Administrative Specialist